MITHRA PHARMACEUTICALS SAMITHRA PHARMACEUTICALS SAMITHRA PHARMACEUTICALS SA

MITHRA PHARMACEUTICALS SA

No trades
See on Supercharts
Market capitalization
‪16.31 M‬USD
−2.94USD
‪−191.50 M‬USD
‪44.32 M‬USD
‪46.54 M‬
Beta (1Y)
0.76

About MITHRA

Headquarters
Liege
Founded
1999
Website
FIGI
BBG00QGSPCH1
Mithra Pharmaceuticals SA is a biotechnology company, which engages in the business of transforming women's health by offering new choices through innovation with a particular focus on contraception and menopause. It operates through the following segments: Product Sales, Out-Licensing, and Other. The Product Sales segment includes complex therapeutics, estetrol, and the remaining portfolio of generic products. The Out-Licensing segment offers partnership deals. The Other segment is involved in the research and development services rendered to third parties. The company was founded by Jean-Michel Foidart and Fran?ois Fornieri on July 8, 1999 and is headquartered in Liege, Belgium.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MITPF is 6.75 USD — it has decreased by 12.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MITHRA PHARMACEUTICALS SA stocks are traded under the ticker MITPF.
MITPF stock is 14.81% volatile and has beta coefficient of 0.76. Check out the list of the most volatile stocks — is MITHRA PHARMACEUTICALS SA there?
Yes, you can track MITHRA PHARMACEUTICALS SA financials in yearly and quarterly reports right on TradingView.
MITPF net income for the last quarter is ‪−135.80 M‬ USD, while the quarter before that showed ‪−55.05 M‬ USD of net income which accounts for −146.68% change. Track more MITHRA PHARMACEUTICALS SA financial stats to get the full picture.
Today MITHRA PHARMACEUTICALS SA has the market capitalization of ‪16.01 M‬, it has decreased by 3.75% over the last week.
No, MITPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MITPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MITHRA PHARMACEUTICALS SA stock right from TradingView charts — choose your broker and connect to your account.
MITPF reached its all-time high on Feb 10, 2020 with the price of 29.20 USD, and its all-time low was 6.75 USD and was reached on Sep 7, 2022.
See other stocks reaching their highest and lowest prices.
We've gathered analysts' opinions on MITHRA PHARMACEUTICALS SA future price: according to them, MITPF price has a max estimate of 3.06 USD and a min estimate of 0.11 USD. Read a more detailed MITHRA PHARMACEUTICALS SA forecast: see what analysts think of MITHRA PHARMACEUTICALS SA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MITHRA PHARMACEUTICALS SA EBITDA is ‪−63.58 M‬ USD, and current EBITDA margin is −142.22%. See more stats in MITHRA PHARMACEUTICALS SA financial statements.